Community Practice

Since pharmacists dispense potentially harmful medications, it is critical that we also impart information about poison control.

Pharmacies often overlook their licensing requirements or fail to discover the extent to which a license is required for a particular activity. Not good.

Letters, e-mails, comments, and posts from Drug Topics readers

Hours after we posted Kim Ankenbruck's “A dose of pharmacy truth: Report from the front lines,” the responses started showing up. Here's a collection of the early returns.

Patients who use statins are consuming more calories and fats than a decade earlier, increasing the risk of obesity, diabetes, and cardiovascular disease, according to a study published online in JAMA Internal Medicine.

Who sez older pharmacists should be put out to pasture? Not these guys - they're too busy working to consider the possibility.

FDA Commissioner Margaret A. Hamburg, MD, defended the agency’s approval of the powerful opioid Zohydro ER (hydrocodone bitartrate) extended-release capsules, explaining that its highest dose is no more potent than the highest strengths of the opioid OxyContin ER (oxycodone) extended-release and extended-release morphine, in an FDA blog posted April 29.

Gov. Scott Walker recently signed a bill into law authorizing physician-pharmacist collaboration in any patient setting throughout Wisconsin.

From controlled substances to retail chains in trouble and back to controlled substances, Drug Topics readers found plenty to talk about during the month of April.

The number of pharmacist jobs in South Carolina increased over the past four years, and the number of pharmacists nearing retirement is likely to create jobs for new graduates, according to a new report.

An eight-week regimen of ledipasvir-sofosbuvir was highly effective in treating non-cirrhotic HCV patients with genotype infection.

Nearly one-third of the ADHD-diagnosed foster-care youth received atypical antipsychotics regardless of age group.

The sublingual tablet provides a new treatment option for patients who decline allergy shots

Study finds that targeting the pharmacy service to patients who are most likely to benefit is important.

“Healthcare professionals should consider whether the benefits of Doribax treatment are likely to exceed its potential risks in patients who develop pneumonia while on ventilators,” says FDA.

There is no testimony without tests. How are we handling ours?

Drugs dispensed by physicians are far more expensive than those dispensed by pharmacies. And there are other issues.

The fight over whether pharmacists serve "patients" or "customers" continues. And now there's a new question: How come a major national pharmacy organization has no opinion?

How does it feel to have your brainchild critiqued by an audience of your peers? Dennis Miller gives us an idea.

They play their company policy, you raise 'em one federal regulation.

Pharmacies that don't use social media will soon go the way of the dinosaur. Here are six tips for making these modalities work for you.

By maintaining a strong knowledge base about HCV infection and management, pharmacists can be a resource to providers and patients alike.

Things aren't as simple as the DEA would have us believe.

Pharmacists and consumers alike need to educate themselves about the proper use of these products, taken either alone or with Rx medications.

As opposition to execution drugs grows, manufacturers are cutting off supplies and compounding pharmacies are under pressure.

Some early adopters - well, beta testers - give us the lowdown on current and future applications of Google Glass in pharmacy.

Conditions targeted by the first guidelines geared specifically to women include migraine, high blood pressure, preeclampsia, and atrial fibrillation.

Once-daily simeprevir should be used in combination with peginterferon alpha and ribavirin. It is not a monotherapy.

Like oral medications, topical analgesics can offer patients well-controlled pain relief, but they do so without adverse systemic effects.

Groundbreaking new therapies for HCV are now available. As experts in screening and treatment guidelines, pharmacists can lead in managing these new options for patient care.